INTRODUCTION
The discrepancy between the amount of lactose being consumed in the diet and the ability to secrete the lactase enzyme underlies the persistence of the chronic inflammatory process and the formation of obesity and insulin resistance. The degree of transcription of the lactase gene (LCT), OMIM 603202NG_008104 depends on the characteristics of the MCM6 (minichromosome maintenance complex 6) enhancer. Single nucleotide polymorphisms (SNP) of the cis-regulatory element MCM6, which are characterized by the replacement of cytosine (C) with thymine (T) in the 13th MCM6 intron at position 13910 for 14 kb from the LCT locus, cause a high penetrance of the lactase gene. The average level of lactase activity in European children with the genotype C/C 13910 is 6.5 U/g (adult-type lactase deficiency, LD), while the activity of lactase with the C/T genotype is 29.9 U/g (heterozygous lactase persistence), and with genotype T/T 50 U/g (homozygous lactase persistence) (1) .
Our study focuses on solving one of the global medical and social problems in pediatrics caused by a significant spread of childhood obesity in an urbanized society (2) with LCT genotypes, studying the factors that cause chronic inflammation.
The aim of this work was to study the factors that induce insulin resistance within obesity in children caused by a genetically determined impairment of lactose digestion.
MATERIALS AND METHODS
To build a mathematical model for predicting the probability of insulin-resistant obesity in the early diagnostic stage, out of 109 children aged 6-18 years, two groups were identified. The main group (n = 56) was presented by children with insulin-resistant obesity according to the recommendations of The European Society of Endocrinology and the Pediatric Endocrine Society (3) . The control group (n = 53) was formed by children with no signs of insulin-resistant obesity.
Genotyping was carried out at the polymorphic locus of the LCT gene by real-time polymerase chain reaction (RT-PCR) in 109 obese children from 6 to 18 years of age in a certified laboratory Synevo. The material for the study was venous blood.
Genotyping for signs of allelic polymorphism of the c.-13910 T>C LCT gene was started on the extraction of genomic DNA from peripheral blood leukocytes using the AmliPrime DNA-Sorb B reagent kit according to the manufacturer's instructions (CFX96 (BioRad), USA). In order to recognize alleles in the studied samples, the following classification was used: Allele 1 -allele, the indicated position of the C → T replacement; Allele 2 is the allele indicated after the C → T replacement position. Amplifications were performed on a CFX 96 amplifier (BioRad, USA) with the addition of up to 20 ng of isolated reaction mixture containing: 20 μg of SNP Genotyping Assay Mix (Applied Biosystems, USA) and 2 ng of Universal PCR Master Mix buffer solution (Applied Biosystems, USA). In the process of amplification, a simultaneous hybridization -fluorescence detection was performed on samples using fluorescent probes on a DNA analyzer according to the Assays-onDemand protocols for SNP genotyping (No 4331183, Applied Biosystems, USA). Thus, three types of amplification products were determined: determination of the fluorescent signal only from the VIC dye -homozygote for gene 1 (genotype C/C 13910), simultaneously fluorescent signals from the dye VIC and FAM -heterozygote for genome 2 (genotype C/T 13910), fluorescent signal only from FAM dye -homozygote for genome 2 (T/T 13910 genotype).
To detect basal insulinemia and glycaemia in venous blood, the Immunochemical Test Method with Electrochemiluminescent Detection (ECLIA) in the Synevo laboratory was used. We calculated the level of sensitivity of peripheral tissues to insulin, the insulin resistance index HOMA (Homeostasis Model Assesment), using the formula (1):
HOMA-IR = (fasting glycaemia (mmol/L) × fasting insulin (μAU/L)) / 22.5 (1) .
HOMA-IR is one of the clinical criteria for insulin resistance. An increase in insulin resistance was observed with HOMA-IR> 95th percentile, respectively, with percentile curves recommended by the IDEFICS Consortium for the European population according to the age and gender of the child (4) .
Hydrogen breath test with lactose load, 25 g (HBTLL). The concentration of hydrogen in exhaled air was determined by the Gastro + Gastrolyser gas analyzer of the British company Bedfont® Scientific Ltd in parts per million (ppm) with an accuracy of ± 1 ppm. Automatic data analysis was performed using GastroCHART software (Bedfont® Scientific Ltd Station Road, Harrietsham, Maidstone, Kent, ME17 1JA, UK). Duration HBTLL was 3 hours at intervals of 30 minutes. A test was considered positive when the level of hydrogen in exhaled air increased after 60 minutes, by more than 20 ppm compared to the basal level and clinical symptoms of lactase intolerance (abdominal pain, flatulence, and diarrhea) appeared on a visual-analogue scale for the next eight hours observations (5) .
In determining the gradation of quantitative variables, generally accepted ideas about the risk factors of obesity complicated with insulin resistance were used (3, (6) (7) (8) .
The algorithm for constructing a prognostic model included the following steps (9): -Calculation of weighted prognostic (diagnostic) coefficients (PC) for each factor using the sequential analysis of Wald and determining the Kullback's informative coefficient (I) for each factor; -Selection of factors with sufficient informativeness (I ≥ 0.5) and the compilation of a prognostic model that included only those signs that had sufficient informativeness; -Calculation of the total score of prognostic factors (ΣPC) for each observation in the study groups; -Definition of logistic regression parameters by total points and calculation of the theoretical probability of insulin-resistant obesity for each observation; -Development of a scale for assessing the probability of insulin-resistant obesity by the total score; -Evaluation of the developed prognostic model with the use of ROC analysis and other statistical criteria.
To predict the disease, we carried out a sequential procedure for summing up diagnostic (prognostic) factors. Prognostic factors corresponded to the signs identified in the patient before reaching the diagnostic threshold. The choice of diagnostic thresholds (the sum of diagnostic factors), allowing to predict the occurrence of pathology, was carried out using errors of type 1 and type 2, and to achieve an accurate prediction probability of 95% focused on the range: ΣPC ≥ 13.0 -pathology is predicted, or ΣPC ≤ −13.0 -the absence of pathology is predicted. Accordingly, in order to achieve a 99% probability of an error-free forecast, we focused on the range of ΣPС ≥ 20.0 and ΣPС ≤ −20.0, respectively. If the amount was in the range between certain diagnostic thresholds, we concluded that there is not enough information to make a decision about the indicated error levels. The obtained sum of points of prognostic factors (ΣPC) for each observation was calculated taking into account the corresponding weight qualification ( Fig. 1 ) and on its basis, the parameters of logistic regression were determined by formulas (2), (3):
where P is the theoretical probability of insulin-resistant obesity in children; ΣPC is the sum of points for a specific patient; b 0 and b 1 are regression coefficients.
The resulting regression equation:
Building a regression equation with the determination of threshold values of the total score allowed us to develop a classification by ΣPC to determine children with low, medium and high risk of developing insulin-resistant obesity. The criterion for assigning a child to a particular risk group was the value of the calculated probability P, which ranges from 0 to 1, and a level greater than 0.5 (or 50%) indicates an increased risk and corresponds to ΣPC more than 10 points.
Statistical processing of research results included calculation of Spearman's rank correlation coefficient, Wald sequential analysis with the use of the STATISTICA software package (version 6.1) of the AGAR 909E415822FA serial number, adapted for biomedical research. ROC analysis and construction of ROC curves was carried out in the software package of the trial version of Medical Software Software 17.4 (MedCalc Software, Ostend, Belgium, https:// www.medcalc.org, 2017).
RESULTS
In 56 children with insulin-resistant obesity (main group) and 53 children without insulin-resistant obesity (control group) aged 6-18, the following lactase gene genotypes were determined. The main group was dominated by the C/C 13910 genotype -in 51.76% of patients (29/56), the C/T 13910 genotype was found in 35.29% of the patients (20/56), the T/T 13910 genotype -only in 12.94% of patients (7/56) . In children of the control group, the C/C 13910 genotype was found in 25% (13/53), the C/T 13910 genotype in 54.17% (29/53), the T/T 13910 genotype in 20.83% (11/53). By gender, in the main clinical group, boys predominated (60.4% versus 39.6%). Then, as among the children of the control group, girls prevailed, the number of which was 58.33% versus 41.66% of boys, but the statistical significance of these differences was not observed (p > 0.05).
Risk factors for the formation of insulin resistance correlate most strongly among themselves in the group of examined children with the LCT C/C 13910 genotype. In this group of examined patients, the presence of insulin-resistant obesity correlates with the level of systolic blood pressure (SBP) -ρ = 0.48 (p < 0.05), the ratio of the waist circumference to the hips (WC/HC) is ρ = 0.45 (p < 0.05). HOMA-IR index before treatment is ρ = 0.54 (p < 0.05), which in turn associated with an indicator of a hydrogen respiratory test with lactose load (HBTLL) > 20 ppm (ρ = 0.41; p < 0.05).
Analysis of the clinical and anamnestic characteristics of children who had various forms of obesity allowed us to separate the risk factors for insulin-resistant obesity at an early diagnostic stage.
To determine the specific weight of each of the 243 analyzed clinical and biological factors, the prognostic factor (PC) was calculated. When comparing the age structure of children with insulin-resistant obesity and metabolically favorable obesity, we found that the minimum risk of insulin resistance is possible at the age from 4 to 8 years (PC −4.5), and the maximum risk -at the age from 12 to 18 years (PC +2.7). Gender features did not have a statistically significant effect on the risk of the formation of metabolically unfavorable obesity.
The risk of insulin resistance increases the complicated antenatal period (PC +3.6); hereditary burden of metabolic syndrome (PC +2,9); the presence of overweight in early childhood (PC +3); the presence of pneumonia at puberty (PC +7); tallness or physical development at the time of the study, above the 67.34th percentile (PC +1.8); violation of puberty initiation (PC +5,8); acne vulgaris (PC +6). Studying the eating behavior of children with various forms of obesity based on food diaries has shown that the average duration of food increases the risk of insulin-resistant obesity to less than 10 minutes (PC +4.5). Then, as a quiet meal during 20 minutes reduces the risk of insulin resistance (PC −6.7). Significantly increases the probability of insulin resistance and nutritional composition. For example, daily consumption of red meat, sausages, potatoes, rice, margarine, sugary drinks increases the risk of the formation of insulin-resistant obesity (PC +6.4). On the contrary, daily consumption of fresh vegetables and fruits in the form of 2-3 portions (children's palms) reduces the risk of insulin resistance (PC −5.5). Lifestyle modification requires reducing non-academic use of a computer/TV or other gadgets to 3 hours per day (PC +4.9). Clinical manifestations of LD in a patient increased the risk of possible insulin-resistant (PC +2.6), as did the presence of the lactase C/C 13910 gene genotype (PC +5.8). The presence of the genotype C/T 13910 has a protective effect on the risk of obesity (PC −2.9). However, the lowest risk of insulin-resistant obesity was observed in children with the genotype T/T 13910 (PC −12).
The ranking according to the Kullback's (I) informative coefficient showed that the first places among the factors that predict insulin-resistant obesity in children at an early diagnostic stage are occupied by the genotype of the lactase gene (I = 3.49), the level of basal insulinemia (I = 3.02) and the lack of daily use up to 2-3 portions of fresh vegetables and fruits (I = 2.71), these factors and others have a high informative significance (3.0 > I ≥ 1.0).
A moderate informative (diagnostic) significance (1.0 > I ≥ 0.50) was characteristic of the pathological course of pregnancy in the proband mother. Low prognostic information (0.5 > I ≥ 0.20) is established for the presence of chickenpox in history, the prevalence of fast food in the diet. These factors have been removed from the prognostic model, Thus, we identified 14 the most prognostically and diagnostically significant clinical and biological predictors of the formation of insulin-resistant obesity in children from 6 to 18 years old, with sufficient informative prognostic significance (I ≥ 0.5), figure 1.
PREDICTORS FORMATION INSULIN RESISTANCE
Kulback's informative coefficient, I The developed prognostic model for the development of morbid obesity in children has excellent operational characteristics, figure 2 .
Sensitivity 94.64%, specificity 84.91% and their generalized indicator is the area under the ROC curve AUC = 0.945 (p < 0.001) with 95% CI 0.884-0.980. Test predict a negative result −83.16%. The proportion of correct prediction of the patient's actual belonging to one group or another (whether it is insulin-resistant obesity or not) was 87.16%, which indicates a high consistency in the actual distribution of observations for the presence of pathological obesity and distribution based on the prognostic model.
DISCUSSION
The presented model for predicting insulin-resistant obesity in children confirmed the data of previous studies on the importance of lifestyle modification: nutrition and physical activity (2, 3, 10) . Excess lactose in the diet of modern humans causes clinical manifestations of genetically determined lactase deficiency (11) . A survey conducted by Lucyna Ostrowska et al. (12) showed that the ability to digest lactose in adult men correlates with low basal hyperinsulinemia. In individuals with the C/C 13910 genotype, reduction of the signaling pathway Gal-9/Tim-3 stimulates the synthesis of pro-inflammatory cytokines and forms a metabolically unfavorable insulin-resistant phenotype.
According to our study, the maximum risk of insulin-resistant was observed at the age from 12 to 17 years. The presence of pneumonia, precisely during puberty (13) , which is characterized by the presence of physiological in-sulin resistance significantly, worsens the risk of metabolic adverse obesity in children.
The data obtained coincide with the results of studies demonstrating the relationship between inhibition of excess galectin-9/Tim-3 signaling pathway by excess lactose and the level of invasiveness of pathological factors (14) .
Violation of the initiation of sexual development has gender dissociation and is associated with the development of normogonadotropic hypogonadism in boys and the syndrome of isolated adrenarche in girls. At the same time, activation of contrinsular hormones explains accelerated physical development and high height with insulin resistance. Chronic hyperinsulinemia, which is primarily compensatory, to support euglycemia, leads to the activation of lipolysis in visceral adipose tissue with the release of free fatty acids (FFA), which is an important metabolic risk factor for dyslipoproteinemia and leptin-resistance progression. FFA, among which acetate (60%), butyrate (15-20%), propionate (20-25%), which also accumulate when excessive use of lactose in the intestinal lumen, interact with the receptor GRP41 enteroendocrine cells of the intestine, causing an increase in the synthesis of the intestinal peptide YY, which slows down the intestinal transit time and reduces the feeling of fullness (7) .
Despite the progress achieved in endocrinology and molecular genetics, the problem of childhood obesity remains highly relevant and requires further research on the influence on key metabolic risk factors. the lactase C/C 13910 gene, basal hyperinsulinemia and the lack of daily consumption of up to 2-3 portions of fresh vegetables and fruits.
To increase the effectiveness of planning personalized preventive and rehabilitation measures for overweight patients, it is proposed that practical doctors use the algorithm we developed for predicting pathological obesity in children with different genotypes of the lactase gene at an early diagnostic stage. The use of lactase gene genotyping and a HBTLL in all overweight patients is recommended to exclude lactose maldigestion. Children with obesity, with the genotype of the C/C 13910 lactase gene and a HBTLL index less than 19 pmm, must be prescribed low-lactose diet therapy with the calculation of the level of lactose tolerance according to the innovative "Low-lactose diet" computer program that we have presented (15) . In children with obesity, with the genotype of the C/C 13910 lactase gene and lactose maldigestion with a HBTLL index of more than 20 pmm, it is necessary to use a combination of low-lactose diet therapy and exogenous lactase drug at a dose of 3000 ALU three times a day for 1 month (16) .
Prevention of insulin-resistant obesity in a child must begin from the moment of birth during the preparation of a genetic passport, especially when there is the hereditary burden of the metabolic syndrome, the pathological course of pregnancy in the mother, macrosomia and the presence of the C/C 13910 genotype of the whole family.
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